Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
| Specialty Retail Industry | Consumer Discretionary Sector | Jack Clifford Bendheim CEO | XFRA Exchange | US71742Q1067 ISIN |
| US Country | 1,940 Employees | 26 Nov 2025 Last Dividend | - Last Split | 11 Apr 2014 IPO Date |
Phibro Animal Health Corporation serves as a multi-national entity dedicated to the health and nutritional needs of animals across the globe, including in the United States, Israel, Brazil, Ireland, among others. With a foundation laid in 1946 and rebranded from Philipp Brothers Chemicals, Inc. to its current name in July 2003, Phibro has established its headquarters in Teaneck, New Jersey. The company is structured around three primary segments: Animal Health, Mineral Nutrition, and Performance Products, catering to a wide range of animal species such as poultry, swine, beef and dairy cattle, aquaculture, and companion animals like dogs. Phibro's operations encompass the development, manufacture, and marketing of an extensive portfolio directed towards enhancing animal health, performance, and welfare, ensuring food safety, and sustaining environmental and agricultural ecosystems.
Animal Health Products:
Antibacterials, anticoccidials, nutritional specialties, vaccines, and vaccine adjuvants – This suite of products is designed to combat bacterial infections, prevent diseases like coccidiosis, and improve the overall health and performance of animals across various sectors. Phibro places a strong emphasis on enhancing food safety and animal welfare through its innovative health solutions.
Microbial and Bioproducts:
Developing, manufacturing, and marketing for animal health and nutrition, industrial, environmental, and agricultural applications – Phibro leverages biotechnology to offer products aimed at improving animal health and nutrition. These solutions also extend to industrial, environmental, and agricultural sectors, showcasing the company's versatile application of microbial and bio-technologies.
Vaccine Products:
Conventionally licensed and autogenous vaccines, along with adjuvants for animal vaccine manufacturers – Phibro plays a pioneering role in the development and manufacture of both standard and custom vaccines tailored to the specific needs of animals. This includes the provision of adjuvants that enhance the effectiveness of these vaccines.
Mineral Nutrition:
Trace minerals and nutritional supplements for livestock diets – With an acute focus on mineral nutrition, Phibro develops and markets formulations rich in essential trace minerals like zinc, manganese, copper, and iron. These products are vital for fortifying animal feeds, ensuring livestock receive balanced dietary nutrition to maintain optimal health and productivity.
Specialty Ingredients:
For personal care, industrial chemical, and chemical catalyst industries – Beyond its core offerings in animal health and nutrition, Phibro extends its expertise to the provision of specialty ingredients catered to the personal care, industrial chemical, and chemical catalyst sectors. This diversification underscores Phibro’s commitment to leveraging its chemical manufacturing prowess across a broad spectrum of industries.
Phibro strategically distributes its agricultural and animal health solutions through its extensive network of local sales offices, targeting integrated poultry, swine, and cattle integrators, as well as commercial animal feed manufacturers, wholesalers, and distributors globally.